Fasting plasma ghrelin concentrations 6 months after gastric bypass are not determined by weight loss or changes in insulinemia

Obesity Surgery

Volumn 14, Issue 9, 2004, Pages 1208-1215

  Frühbeck, Gema ^a   Rotellar, Fernando ^a   Hernández Lizoain, José Luis ^a   Gil, M Jesús ^a   Gómez Ambrosi, Javier ^a   Salvador, Javier ^a   Cienfuegos, Javier A ^a  

^a UNIVERSITY CLINIC OF NAVARRA   (Spain)

Author keywords

Adjustable gastric banding; Gastrointestinal signals; Ghrelin; Morbid obesity; Roux en Y gastric bypass; Weight loss

Indexed keywords

GHRELIN; INSULIN;

ADULT; ARTICLE; BLOOD LEVEL; BODY COMPOSITION; BODY MASS; BODY WEIGHT; CLINICAL ARTICLE; COMPARATIVE STUDY; CONTROLLED STUDY; DIET THERAPY; FOLLOW UP; GASTRECTOMY; GASTRIC BANDING; HUMAN; INSULIN SENSITIVITY; INSULINEMIA; MALE; MORBID OBESITY; PRIORITY JOURNAL; ROUX Y ANASTOMOSIS; STOMACH BYPASS; SURGICAL TECHNIQUE; TOTAL STOMACH RESECTION; TREATMENT OUTCOME; WEIGHT REDUCTION;

ADULT; ENERGY INTAKE; FASTING; GASTRIC BYPASS; GASTRIC FUNDUS; HUMANS; INSULIN; MALE; PEPTIDE HORMONES; POSTOPERATIVE PERIOD; WEIGHT LOSS;

EID: 7644225803     PISSN: 09608923     EISSN: None     Source Type: Journal    
DOI: 10.1381/0960892042386904     Document Type: Article

References (53)

1. Freedman DS, Khan LK, Serdula MK et al. Trends and correlates of class 3 obesity in the United States from 1990 through 2000. JAMA 2002; 288: 1758-61.
2. Hedley AA, Ogden CL, Johnson CL et al. Prevalence of overweight and obesity among US children, adolescents, and adults, 1999-2002. JAMA 2004; 291: 2847-50.
3. Hill JO, Wyatt HR, Reed GW et al. Obesity and the environment: where do we go from here? Science 2003; 299: 853-5.
4. Pi-Sunyer X. A clinical view of the obesity problem. Science 2003; 299: 859-60.
5. Korner J, Aronne LJ. The emerging science of body weight regulation and its impact on obesity treatment. J Clin Invest 2003; 111: 565-70.
6. Frühbeck G, Gómez-Ambrosi J. Control of body weight: a physiologic and transgenic perspective. Diabetologia 2003; 46: 143-72.
7. Flier JS. Obesity wars: molecular progress confronts an expanding epidemic. Cell 2004; 116: 337-50.
8. Havel PJ. Peripheral signals conveying metabolic information to the brain: short-term and long-term regulation of food intake and energy homeostasis. Exp Biol Med 2001; 226: 963-77.
9. Inui A, Asakawa A, Bowers CY et al. Ghrelin, appetite, and gastric motility: the emerging role of the stomach as an endocrine organ. FASEB J 2004; 18: 439-56.
10. Van der Lely AJ, Tschöp M, Heiman ML et al. Biological, physiological, and pharmacological aspects of ghrelin. Endocrine Rev 2004; 25: 426-57.
11. Date Y, Kojima M, Hosoda H et al. Ghrelin, a novel growth hormone-releasing acylated peptide, is synthesized in a distinct endocrine cell type in the gastrointestinal tracts of rats and humans. Endocrinology 2000; 141: 4255-61.
12. Ariyasu H, Takaya K, Tagami T et al. Stomach is a major source of circulating ghrelin, and feeding state determines plasma ghrelin-like immunoreactivity levels in humans. J Clin Endocrinol Metab 2001; 86: 4753-8.
13. Lee H-M, Wang G, Englander EW et al. Ghrelin, a new gastrointestinal endocrine peptide that stimulates insulin secretion: enteric distribution, ontogeny, influence of endocrine, and dietary manipulations. Endocrinology 2002; 143: 185-90.
14. Sakata I, Nakamura K, Yamazaki M et al. Ghrelin-producing cells exist as two types of cells, closed- and opened-type cells, in the rat gastrointestinal tract. Peptides 2002; 23: 531-6.
15. Gnanapavan S, Kola B, Bustin SA et al. The tissue distribution of the mRNA of ghrelin and subtypes of its receptor, GHS-R, in humans. J Clin Endocrinol Metab 2002; 87: 2988-91.
16. Tschöp M, Smiley DL, Heiman ML. Ghrelin induces adiposity in rodents. Nature 2000; 407: 908-13.
17. Kamegai J, Tamura H, Shimizu T et al. Central effect of ghrelin, an endogenous GH secretagogue, on hypothalamic peptide gene expression. Endocrinology 2000; 141: 4797-800.
18. Wren AM, Seal LJ, Cohen MA et al. Ghrelin enhances appetite and increases food intake in humans. J Clin Endocrinol Metab 2001; 86: 5992-5.
19. Cummings DE, Purnell JQ, Frayo RS et al. A preprandial rise in plasma ghrelin levels suggests a role in meal initiation in humans. Diabetes 2001; 50: 1714-9.
20. Tschöp M, Weyer C, Tataranni PA et al. Circulating ghrelin levels are decreased in human obesity. Diabetes 2001; 50: 707-9.
21. Shiiya T, Nakazato M, Mizuta M et al. Plasma ghrelin levels in lean and obese humans and the effect of glucose on ghrelin secretion. J Clin Endocrinol Metab 2002; 87: 240-4.
22. Cummings DE, Weigle DS, Frayo RS et al. Plasma ghrelin levels after diet-induced weight loss or gastric bypass surgery. N Engl J Med 2002; 346: 1623-30.
23. Brolin RE. Bariatric surgery and long-term control of morbid obesity. JAMA 2002; 288: 2793-6.
24. Trostler N, Mann A, Zilberbush N et al. Weight loss and food intake 18 months following vertical banded gastroplasty or gastric bypass for severe obesity. Obes Surg 1995; 5: 39-51.
25. Faraj M, Havel PJ, Phélis S et al. Plasma acylation-stimulating protein, adiponectin, leptin and ghrelin before and after weight loss induced by gastric bypass surgery in morbidly obese subjects. J Clin Endocrinol Metab 2003; 88: 1594-1602.
26. Holdstock C, Engström BE, Öhrvall M et al. Ghrelin and adipose tissue regulatory peptides: effect of gastric bypass surgery in obese humans. J Clin Endocrinol Metab 2003; 88: 3177-83.
27. Geloneze B, Tambascia MA, Pilla VF et al. Ghrelin: a gut-brain hormone: effect of gastric bypass surgery. Obes Surg 2003; 13: 17-22.
28. Adami GF, Cordera R, Marinari G et al. Plasma ghrelin concentration in the short-term following biliopancreatic diversion. Obes Surg 2003; 13: 889-92.
29. Hanush-Enserer U, Brabant G, Roden M. Ghrelin concentrations in morbidly obese patients after adjustable gastric banding. N Engl J Med 2003; 348: 2159-60.
30. Stoeckli R, Chanda R, Langer I et al. Changes of body weight and plasma ghrelin levels after gastric banding and gastric bypass. Obes Res 2004; 12: 346-350.
31. Nijhuis J, van Dielen FMH, Buurman WA et al. Ghrelin, leptin and insulin levels after restrictive surgery: a 2-year follow-up study. Obes Surg 2004; 14: 783-7.
32. Frühbeck G, Diez-Caballero A, Gil MJ et al. The decrease in plasma ghrelin concentrations following bariatric surgery depends on the functional integrity of the fundus. Obes Surg 2004; 14: 606-12.
33. Frühbeck G, Diez-Caballero A, Gil MJ. Fundus functionality and ghrelin concentrations after bariatric surgery. N Engl J Med 2004; 350: 308-9.
34. Belachew M, Belva PH, Desaive C. Long-term results of laparoscopic adjustable gastric banding for the treatment of morbid obesity. Obes Surg 2002; 12: 564-8.
35. Wittgrove AC, Clark GW. Laparoscopic gastric bypass, Roux-en-Y - 500 patients: technique and results with 3-60 month follow-up. Obes Surg 2000; 10: 233-9.
36. Sardinha LB, Lohman TG, Teixeira PJ et al. Comparison of air displacement plethysmograph with dual-energy X-ray absorptiometry and 3 field methods for estimating body composition in middle-aged men. Am J Clin Nutr 1998; 68: 786-93.
37. Wells JCK, Fuller NJ. Precision of measurement and body size in whole-body air-displacement plethysmography. Int J Obes 2001; 25: 1161-7.
38. Das SK, Roberts SB, Kehayias JJ et al. Body composition characterization and method validation in extreme obesity and following massive weight loss induced by gastric bypass surgery. Am J Physiol Endocrinol Metab 2003; 284: E1080-8.
39. Trinder P. Determination of blood glucose using an oxidase-peroxidase system with a non-carcinogenic chromogen. J Clin Pathol 1969; 22: 158-61.
40. Friedewald WT, Levy RI, Fredrickson S. Estimation of the concentration of low density lipoprotein cholesterol in plasma, without the use of preparative ultra-centrifuge. Clin Chem 1972; 18: 499-502.
41. Katz A, Nambi SS, Mather K et al. Quantitative insulin sensitivity check index: a simple, accurate method for assessing insulin sensitivity in humans. J Clin Endocrinol Metab 2000; 85: 2402-10.
42. Bonora E, Targher G, Alberiche M et al. Homeostasis model assessment closely mirrors the glucose clamp technique in the assessment of insulin sensitivity. Studies in subjects with various degrees of glucose tolerance and insulin sensitivity. Diabetes Care 2000; 23: 57-63.
43. Pories WJ, Swanson MS, MacDonald KG et al. Who would have thought it? An operation proves to be the most effective therapy for adult-onset diabetes mellitus. Ann Surg 1995; 222: 339-50.
44. Hansen TK, Dall R, Hosoda H et al. Weight loss increases circulating levels of ghrelin in human obesity. Clin Endocrinol 2002; 56: 203-6.
45. Schöfl C, Horn R, Schill T et al. Circulating ghrelin levels in patients with polycystic ovary syndrome. J Clin Endocrinol Metab 2002; 87: 4607-10.
46. Leidy HJ, Gardner JK, Frye BR et al. Circulating ghrelin is sensitive to changes in body weight during a diet and exercise program in normal-weight young women. J Clin Endocrinol Metab 2004; 89: 2959-64.
47. Cummings DE, Shannon MH. Ghrelin and gastric bypass: is there a hormonal contribution to surgical weight loss? J Clin Endocrinol Metab 2003; 88: 2999-3002.
48. Almogy G, Crookes PF, Anthone GJ. Longitudinal gastrectomy as a treatment for the high-risk super-obese patient. Obes Surg 2004; 14: 492-7.
49. Saad MF, Bernaba B, Hwu CM et al. Insulin regulates plasma ghrelin concentration. J Clin Endocrinol Metab 2002; 87: 3997-4000.
50. Schaller G, Schmidt A, Pleiner J et al. Plasma ghrelin concentrations are not regulated by glucose or insulin. A double-blind, placebo-controlled crossover clamp study. Diabetes 2003; 52: 16-20.
51. Flanagan DE, Evans ML, Monsod TP et al. The influence of insulin on circulating ghrelin. Am J Physiol Endocrinol Metab 2003; 284: E313-6.
52. Ukkola O. Ghrelin and insulin metabolism. Eur J Endocrinol 2003; 33: 183-5.
53. Cummings DE, Overduin J, Foster-Schubert KE. Gastric bypass for obesity: mechanisms of weight loss and diabetes resolution. J Clin Endocrinol Metab 2004; 89: 2608-15.